$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Chimeric Antigen Receptor T-cell Therapy for Cancer: A Basic Research-Oriented Perspective

Immunotherapy, v.10 no.3, 2018년, pp.221 - 234  

Han, Chungyong (Immunotherapeutics Branch, Division of Convergence Technology Research Institute, National Cancer Center, Goyang10408, Korea) ,  Kwon, Byoung S (Immunotherapeutics Branch, Division of Convergence Technology Research Institute, National Cancer Center, Goyang10408, Korea)

Abstract AI-Helper 아이콘AI-Helper

Chimeric antigen receptor (CAR) T cells have outstanding therapeutic potential for treating blood cancers. The prospects for this technology have accelerated basic research, clinical translation and Big Pharma's investment in the field of T-cell therapeutics. This interest has led to the discovery o...

참고문헌 (146)

  1. Themeli, M., Riviere, I., Sadelain, M.. New Cell Sources for T Cell Engineering and Adoptive Immunotherapy. Cell stem cell, vol.16, no.4, 357-366.

  2. Rosenberg, Steven A., Restifo, Nicholas P.. Adoptive cell transfer as personalized immunotherapy for human cancer. Science, vol.348, no.6230, 62-68.

  3. Lim, Wendell A., June, Carl H.. The Principles of Engineering Immune Cells to Treat Cancer. Cell, vol.168, no.4, 724-740.

  4. Mitchison, N. A.. STUDIES ON THE IMMUNOLOGICAL RESPONSE TO FOREIGN TUMOR TRANSPLANTS IN THE MOUSE : I. THE ROLE OF LYMPH NODE CELLS IN CONFERRING IMMUNITY BY ADOPTIVE TRANSFER. The Journal of experimental medicine, vol.102, no.2, 157-177.

  5. Rosenberg, Steven A., Lotze, Michael T., Muul, Linda M., Leitman, Susan, Chang, Alfred E., Ettinghausen, Stephen E., Matory, Yvedt L., Skibber, John M., Shiloni, Eitan, Vetto, John T., Seipp, Claudia A., Simpson, Colleen, Reichert, Cheryl M.. Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer. The New England journal of medicine, vol.313, no.23, 1485-1492.

  6. Rosenberg, SA, Spiess, P, Lafreniere, R. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science, vol.233, no.4770, 1318-1321.

  7. Cancer Res. Valmori D 2167 59 9 1999 An antigen-targeted approach to adoptive transfer therapy of cancer Valmori D , PittetMJ , RimoldiDet al. An antigen-targeted approach to adoptive transfer therapy of cancer . Cancer Res.59 ( 9 ), 2167 - 2173 ( 1999 ). 

  8. Yron, I, Wood Jr, T A, Spiess, P J, Rosenberg, S A. In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.. The journal of immunology : official journal of the American Association of Immunologists, vol.125, no.1, 238-245.

  9. Rosenberg, Steven A., Packard, Beverly S., Aebersold, Paul M., Solomon, Diane, Topalian, Suzanne L., Toy, Stephen T., Simon, Paul, Lotze, Michael T., Yang, James C., Seipp, Claudia A., Simpson, Colleen, Carter, Charles, Bock, Steven, Schwartzentruber, Douglas, Wei, John P., White, Donald E.. Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma. The New England journal of medicine, vol.319, no.25, 1676-1680.

  10. Chandran, Smita S, Somerville, Robert P T, Yang, James C, Sherry, Richard M, Klebanoff, Christopher A, Goff, Stephanie L, Wunderlich, John R, Danforth, David N, Zlott, Daniel, Paria, Biman C, Sabesan, Arvind C, Srivastava, Abhishek K, Xi, Liqiang, Pham, Trinh H, Raffeld, Mark, White, Donald E, Toomey, Mary Ann, Rosenberg, Steven A, Kammula, Udai S. Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study. The Lancet. Oncology, vol.18, no.6, 792-802.

  11. Rivoltini, L, Kawakami, Y, Sakaguchi, K, Southwood, S, Sette, A, Robbins, P F, Marincola, F M, Salgaller, M L, Yannelli, J R, Appella, E. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1.. The journal of immunology : official journal of the American Association of Immunologists, vol.154, no.5, 2257-2265.

  12. Choi, Beom K., Lee, Sang C., Lee, Myoung J., Kim, Young H., Kim, Young-Woo, Ryu, Keun-Won, Lee, Jun-Ho, Shin, Su M., Lee, Sang-Ho, Suzuki, Susumu, Oh, Ho S., Kim, Chang H., Lee, Don G., Hwang, Sun H., Yu, Eun-Mi, Lee, In O., Kwon, Byoung S.. 4-1BB-based Isolation and Expansion of CD8+ T Cells Specific for Self-Tumor and Non–Self-Tumor Antigens for Adoptive T-cell Therapy. Journal of immunotherapy, vol.37, no.4, 225-236.

  13. Eom, Hyeon-Seok, Choi, Beom K., Lee, Youngjoo, Lee, Hyewon, Yun, Tak, Kim, Young H., Lee, Je-Jung, Kwon, Byoung S.. Phase I Clinical Trial of 4-1BB-based Adoptive T-Cell Therapy for Epstein-Barr Virus (EBV)-positive Tumors. Journal of immunotherapy, vol.39, no.3, 140-148.

  14. Mulligan, RC. The basic science of gene therapy. Science, vol.260, no.5110, 926-932.

  15. Naldini, Luigi, Blömer, Ulrike, Gallay, Philippe, Ory, Daniel, Mulligan, Richard, Gage, Fred H., Verma, Inder M., Trono, Didier. In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector. Science, vol.272, no.5259, 263-267.

  16. Porter, David L., Levine, Bruce L., Kalos, Michael, Bagg, Adam, June, Carl H.. Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia. The New England journal of medicine, vol.365, no.8, 725-733.

  17. Kochenderfer, James N., Dudley, Mark E., Feldman, Steven A., Wilson, Wyndham H., Spaner, David E., Maric, Irina, Stetler-Stevenson, Maryalice, Phan, Giao Q., Hughes, Marybeth S., Sherry, Richard M., Yang, James C., Kammula, Udai S., Devillier, Laura, Carpenter, Robert, Nathan, Debbie-Ann N., Morgan, Richard A., Laurencot, Carolyn, Rosenberg, Steven A.. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. Blood, vol.119, no.12, 2709-2720.

  18. Grupp, Stephan A., Kalos, Michael, Barrett, David, Aplenc, Richard, Porter, David L., Rheingold, Susan R., Teachey, David T., Chew, Anne, Hauck, Bernd, Wright, J. Fraser, Milone, Michael C., Levine, Bruce L., June, Carl H.. Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia. The New England journal of medicine, vol.368, no.16, 1509-1518.

  19. Brentjens, Renier J., Davila, Marco L., Riviere, Isabelle, Park, Jae, Wang, Xiuyan, Cowell, Lindsay G., Bartido, Shirley, Stefanski, Jolanta, Taylor, Clare, Olszewska, Malgorzata, Borquez-Ojeda, Oriana, Qu, Jinrong, Wasielewska, Teresa, He, Qing, Bernal, Yvette, Rijo, Ivelise V., Hedvat, Cyrus, Kobos, Rachel, Curran, Kevin, Steinherz, Peter, Jurcic, Joseph, Rosenblat, Todd, Maslak, Peter, Frattini, Mark, Sadelain, Michel. CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia. Science translational medicine, vol.5, no.177,

  20. Kuwana, Yoshihisa, Asakura, Yoshihiro, Utsunomiya, Naoko, Nakanishi, Mamoru, Arata, Yohji, Itoh, Seiga, Nagase, Fumihiko, Kurosawa, Yoshikazu. Expression of chimeric receptor composed of immunoglobulin-derived V resions and T-cell receptor-derived C regions. Biochemical and biophysical research communications, vol.149, no.3, 960-968.

  21. Gross, G, Waks, T, Eshhar, Z. Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.. Proceedings of the National Academy of Sciences of the United States of America, vol.86, no.24, 10024-10028.

  22. Irving, B.A., Weiss, A.. The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathways. Cell, vol.64, no.5, 891-901.

  23. Romeo, C., Seed, B.. Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides. Cell, vol.64, no.5, 1037-1046.

  24. Letourneur, F, Klausner, R D. T-cell and basophil activation through the cytoplasmic tail of T-cell-receptor zeta family proteins.. Proceedings of the National Academy of Sciences of the United States of America, vol.88, no.20, 8905-8909.

  25. Riddell, Stanley R., Elliott, Mark, Lewinsohn, Deborah A., Gilbert, Mark J., Wilson, Linda, Manley, Sara A., Lupton, Stephen D., Overell, Robert W., Reynolds, Thomas C., Corey, Lawrence, Greenberg, Philip D.. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nature medicine, vol.2, no.2, 216-223.

  26. Mitsuyasu, Ronald T., Anton, Peter A., Deeks, Steven G., Scadden, David T., Connick, Elizabeth, Downs, Matthew T., Bakker, Andreas, Roberts, Margo R., June, Carl H., Jalali, Sayeh, Lin, Andy A., Pennathur-Das, Rukmini, Hege, Kristen M.. Prolonged survival and tissue trafficking following adoptive transfer of CD4ζ gene-modified autologous CD4+ and CD8+ T cells in human immunodeficiency virus-infected subjects. Blood, vol.96, no.3, 785-793.

  27. Deeks, Steven G., Wagner, Bridget, Anton, Peter A., Mitsuyasu, Ronald T., Scadden, David T., Huang, Christine, Macken, Catherine, Richman, Douglas D., Christopherson, Cindy, June, Carl H., Lazar, Richard, Broad, David F., Jalali, Sayeh, Hege, Kristen M.. A Phase II Randomized Study of HIV-Specific T-Cell Gene Therapy in Subjects with Undetectable Plasma Viremia on Combination Antiretroviral Therapy. Molecular therapy : the journal of the American Society of Gene Therapy, vol.5, no.6, 788-797.

  28. Scholler, John, Brady, Troy L., Binder-Scholl, Gwendolyn, Hwang, Wei-Ting, Plesa, Gabriela, Hege, Kristen M., Vogel, Ashley N., Kalos, Michael, Riley, James L., Deeks, Steven G., Mitsuyasu, Ronald T., Bernstein, Wendy B., Aronson, Naomi E., Levine, Bruce L., Bushman, Frederic D., June, Carl H.. Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells. Science translational medicine, vol.4, no.132,

  29. Maude, Shannon L., Frey, Noelle, Shaw, Pamela A., Aplenc, Richard, Barrett, David M., Bunin, Nancy J., Chew, Anne, Gonzalez, Vanessa E., Zheng, Zhaohui, Lacey, Simon F., Mahnke, Yolanda D., Melenhorst, Jan J., Rheingold, Susan R., Shen, Angela, Teachey, David T., Levine, Bruce L., June, Carl H., Porter, David L., Grupp, Stephan A.. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia. The New England journal of medicine, vol.371, no.16, 1507-1517.

  30. Lee, D.W., Kochenderfer, J.N., Stetler-Stevenson, M., Cui, Y.K., Delbrook, C., Feldman, S.A., Fry, T.J., Orentas, R., Sabatino, M., Shah, N.N., Steinberg, S.M., Stroncek, D., Tschernia, N., Yuan, C., Zhang, H., Zhang, L., Rosenberg, S.A., Wayne, A.S., Mackall, C.L.. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial. The Lancet, vol.385, no.9967, 517-528.

  31. Porter, David L., Hwang, Wei-Ting, Frey, Noelle V., Lacey, Simon F., Shaw, Pamela A., Loren, Alison W., Bagg, Adam, Marcucci, Katherine T., Shen, Angela, Gonzalez, Vanessa, Ambrose, David, Grupp, Stephan A., Chew, Anne, Zheng, Zhaohui, Milone, Michael C., Levine, Bruce L., Melenhorst, Jan J., June, Carl H.. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia. Science translational medicine, vol.7, no.303, 303ra139-303ra139.

  32. Hu, Yongxian, Wu, Zhao, Luo, Yi, Shi, Jimin, Yu, Jian, Pu, Chengfei, Liang, Zuyu, Wei, Guoqing, Cui, Qu, Sun, Jie, Jiang, Jing, Xie, Jue, Tan, Yamin, Ni, Wanmao, Tu, Jifang, Wang, Jinping, Jin, Aiyun, Zhang, Hao, Cai, Zhen, Xiao, Lei, Huang, He. Potent Anti-leukemia Activities of Chimeric Antigen Receptor–Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic Leukemia. Clinical Cancer research : an official journal of the American Association for Cancer Research, vol.23, no.13, 3297-3306.

  33. Kochenderfer, James N., Somerville, Robert P.T., Lu, Tangying, Shi, Victoria, Bot, Adrian, Rossi, John, Xue, Allen, Goff, Stephanie L., Yang, James C., Sherry, Richard M., Klebanoff, Christopher A., Kammula, Udai S., Sherman, Marika, Perez, Arianne, Yuan, Constance M., Feldman, Tatyana, Friedberg, Jonathan W., Roschewski, Mark J., Feldman, Steven A., McIntyre, Lori, Toomey, Mary Ann, Rosenberg, Steven A.. Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.35, no.16, 1803-1813.

  34. Turtle, Cameron J., Hay, Kevin A., Hanafi, Laïla-Aïcha, Li, Daniel, Cherian, Sindhu, Chen, Xueyan, Wood, Brent, Lozanski, Arletta, Byrd, John C., Heimfeld, Shelly, Riddell, Stanley R., Maloney, David G.. Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.35, no.26, 3010-3020.

  35. Flemming, Alexandra. Deal watch: Pfizer and GSK join race for T cell cancer therapies. Nature reviews. Drug discovery, vol.13, no.8, 568-569.

  36. June, Carl H., Riddell, Stanley R., Schumacher, Ton N.. Adoptive cellular therapy: A race to the finish line. Science translational medicine, vol.7, no.280, 280ps7-280ps7.

  37. Cooper, Laurence J. N., Topp, Max S., Serrano, Lisa Marie, Gonzalez, Sergio, Chang, Wen-Chung, Naranjo, Araceli, Wright, Christine, Popplewell, Leslie, Raubitschek, Andrew, Forman, Stephen J., Jensen, Michael C.. T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect. Blood, vol.101, no.4, 1637-1644.

  38. Savoldo, Barbara, Ramos, Carlos Almeida, Liu, Enli, Mims, Martha P., Keating, Michael J., Carrum, George, Kamble, Rammurti T., Bollard, Catherine M., Gee, Adrian P., Mei, Zhuyong, Liu, Hao, Grilley, Bambi, Rooney, Cliona M., Heslop, Helen E., Brenner, Malcolm K., Dotti, Gianpietro. CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients. The Journal of clinical investigation, vol.121, no.5, 1822-1826.

  39. Maher, John, Brentjens, Renier J., Gunset, Gertrude, Rivière, Isabelle, Sadelain, Michel. Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor. Nature biotechnology, vol.20, no.1, 70-75.

  40. Imai, C, Mihara, K, Andreansky, M, Nicholson, I C, Pui, C-H, Geiger, T L, Campana, D. Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, vol.18, no.4, 676-684.

  41. Kowolik, Claudia M., Topp, Max S., Gonzalez, Sergio, Pfeiffer, Timothy, Olivares, Simon, Gonzalez, Nancy, Smith, David D., Forman, Stephen J., Jensen, Michael C., Cooper, Laurence J.N.. CD28 Costimulation Provided through a CD19-Specific Chimeric Antigen Receptor EnhancesIn vivoPersistence and Antitumor Efficacy of Adoptively Transferred T Cells. Cancer research : the official organ of the American Association for Cancer Research, Inc, vol.66, no.22, 10995-11004.

  42. Milone, Michael C., Fish, Jonathan D., Carpenito, Carmine, Carroll, Richard G., Binder, Gwendolyn K., Teachey, David, Samanta, Minu, Lakhal, Mehdi, Gloss, Brian, Danet-Desnoyers, Gwenn, Campana, Dario, Riley, James L., Grupp, Stephan A., June, Carl H.. Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo. Molecular therapy : the journal of the American Society of Gene Therapy, vol.17, no.8, 1453-1464.

  43. Esensten, Jonathan H., Helou, Ynes A., Chopra, G., Weiss, A., Bluestone, Jeffrey A.. CD28 Costimulation: From Mechanism to Therapy. Immunity, vol.44, no.5, 973-988.

  44. Yonezawa, Atsushi, Dutt, Suparna, Chester, Cariad, Kim, Jeewon, Kohrt, Holbrook E.. Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy. Clinical Cancer research : an official journal of the American Association for Cancer Research, vol.21, no.14, 3113-3120.

  45. Chester, Cariad, Ambulkar, Siddhant, Kohrt, Holbrook E.. 4-1BB agonism: adding the accelerator to cancer immunotherapy. Cancer immunology, immunotherapy : CII, vol.65, no.10, 1243-1248.

  46. Brentjens, Renier J., Santos, Elmer, Nikhamin, Yan, Yeh, Raymond, Matsushita, Maiko, La Perle, Krista, Quintás-Cardama, Alfonso, Larson, Steven M., Sadelain, Michel. Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts. Clinical Cancer research : an official journal of the American Association for Cancer Research, vol.13, no.18, 5426-5435.

  47. Carpenito, Carmine, Milone, Michael C., Hassan, Raffit, Simonet, Jacqueline C., Lakhal, Mehdi, Suhoski, Megan M., Varela-Rohena, Angel, Haines, Kathleen M., Heitjan, Daniel F., Albelda, Steven M., Carroll, Richard G., Riley, James L., Pastan, Ira, June, Carl H.. Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains. Proceedings of the National Academy of Sciences of the United States of America, vol.106, no.9, 3360-3365.

  48. Long, Adrienne H., Haso, Waleed M., Shern, Jack F., Wanhainen, Kelsey M., Murgai, Meera, Ingaramo, Maria, Smith, Jillian P., Walker, Alec J., Kohler, M. Eric, Venkateshwara, Vikas R., Kaplan, Rosandra N., Patterson, George H., Fry, Terry J., Orentas, Rimas J., Mackall, Crystal L.. 4-1BB Costimulation Ameliorates T Cell Exhaustion Induced by Tonic Signaling of Chimeric Antigen Receptors. Nature medicine, vol.21, no.6, 581-590.

  49. Kawalekar, O.U., O'Connor, R.S., Fraietta, J.A., Guo, L., McGettigan, S.E., Posey, A.D., Patel, P.R., Guedan, S., Scholler, J., Keith, B., Snyder, N.W., Blair, I.A., Milone, M.C., June, C.H.. Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells. Immunity, vol.44, no.2, 380-390.

  50. Kochenderfer, James N., Wilson, Wyndham H., Janik, John E., Dudley, Mark E., Stetler-Stevenson, Maryalice, Feldman, Steven A., Maric, Irina, Raffeld, Mark, Nathan, Debbie-Ann N., Lanier, Brock J., Morgan, Richard A., Rosenberg, Steven A.. Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19. Blood, vol.116, no.20, 4099-4102.

  51. Kalos, Michael, Levine, Bruce L., Porter, David L., Katz, Sharyn, Grupp, Stephan A., Bagg, Adam, June, Carl H.. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia. Science translational medicine, vol.3, no.95,

  52. Davila, Marco L., Riviere, Isabelle, Wang, Xiuyan, Bartido, Shirley, Park, Jae, Curran, Kevin, Chung, Stephen S., Stefanski, Jolanta, Borquez-Ojeda, Oriana, Olszewska, Malgorzata, Qu, Jinrong, Wasielewska, Teresa, He, Qing, Fink, Mitsu, Shinglot, Himaly, Youssif, Maher, Satter, Mark, Wang, Yongzeng, Hosey, James, Quintanilla, Hilda, Halton, Elizabeth, Bernal, Yvette, Bouhassira, Diana C. G., Arcila, Maria E., Gonen, Mithat, Roboz, Gail J., Maslak, Peter, Douer, Dan, Frattini, Mark G., Giralt, Sergio, Sadelain, Michel, Brentjens, Renier. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia. Science translational medicine, vol.6, no.224, 224ra25-224ra25.

  53. Kochenderfer, James N., Dudley, Mark E., Kassim, Sadik H., Somerville, Robert P.T., Carpenter, Robert O., Stetler-Stevenson, Maryalice, Yang, James C., Phan, Giao Q., Hughes, Marybeth S., Sherry, Richard M., Raffeld, Mark, Feldman, Steven, Lu, Lily, Li, Yong F., Ngo, Lien T., Goy, Andre, Feldman, Tatyana, Spaner, David E., Wang, Michael L., Chen, Clara C., Kranick, Sarah M., Nath, Avindra, Nathan, Debbie-Ann N., Morton, Kathleen E., Toomey, Mary Ann, Rosenberg, Steven A.. Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.33, no.6, 540-549.

  54. Zhong, Xiao-Song, Matsushita, Maiko, Plotkin, Jason, Riviere, Isabelle, Sadelain, Michel. Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell-mediated Tumor Eradication. Molecular therapy : the journal of the American Society of Gene Therapy, vol.18, no.2, 413-420.

  55. Morgan, Richard A, Yang, James C, Kitano, Mio, Dudley, Mark E, Laurencot, Carolyn M, Rosenberg, Steven A. Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2. Molecular therapy : the journal of the American Society of Gene Therapy, vol.18, no.4, 843-851.

  56. Till, Brian G., Jensen, Michael C., Wang, Jinjuan, Qian, Xiaojun, Gopal, Ajay K., Maloney, David G., Lindgren, Catherine G., Lin, Yukang, Pagel, John M., Budde, Lihua E., Raubitschek, Andrew, Forman, Stephen J., Greenberg, Philip D., Riddell, Stanley R., Press, Oliver W.. CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results. Blood, vol.119, no.17, 3940-3950.

  57. Guedan, Sonia, Chen, Xi, Madar, Aviv, Carpenito, Carmine, McGettigan, Shannon E., Frigault, Matthew J., Lee, Jihyun, Posey Jr, Avery D., Scholler, John, Scholler, Nathalie, Bonneau, Richard, June, Carl H.. ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells. Blood, vol.124, no.7, 1070-1080.

  58. Finney, Helene M., Akbar, Arne N., Lawson, Alastair D. G.. Activation of Resting Human Primary T Cells with Chimeric Receptors: Costimulation from CD28, Inducible Costimulator, CD134, and CD137 in Series with Signals from the TCRζ Chain. The journal of immunology : official journal of the American Association of Immunologists, vol.172, no.1, 104-113.

  59. Hombach, Andreas A., Heiders, Johannes, Foppe, Marcel, Chmielewski, Markus, Abken, Hinrich. OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4 + T cells. Oncoimmunology, vol.1, no.4, 458-466.

  60. Song, De-Gang, Ye, Qunrui, Poussin, Mathilde, Harms, Gretchen M., Figini, Mariangela, Powell Jr, Daniel J.. CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo. Blood, vol.119, no.3, 696-706.

  61. Guest, Ryan D, Hawkins, Robert E, Kirillova, Natalia, Cheadle, Eleanor J, Arnold, Jennifer, O’Neill, Allison, Irlam, Joely, Chester, Kerry A, Kemshead, John T, Shaw, David M, Embleton, M J, Stern, Peter L, Gilham, David E. The Role of Extracellular Spacer Regions in the Optimal Design of Chimeric Immune Receptors: Evaluation of Four Different scFvs and Antigens. Journal of immunotherapy, vol.28, no.3, 203-211.

  62. James, Scott E., Greenberg, Philip D., Jensen, Michael C., Lin, Yukang, Wang, Jinjuan, Till, Brian G., Raubitschek, Andrew A., Forman, Stephen J., Press, Oliver W.. Antigen Sensitivity of CD22-Specific Chimeric TCR Is Modulated by Target Epitope Distance from the Cell Membrane. The journal of immunology : official journal of the American Association of Immunologists, vol.180, no.10, 7028-7038.

  63. Park, Jae H., Geyer, Mark B., Brentjens, Renier J.. CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date. Blood, vol.127, no.26, 3312-3320.

  64. Brudno, Jennifer N., Kochenderfer, James N.. Chimeric antigen receptor T-cell therapies for lymphoma. Nature reviews. Clinical oncology, vol.15, no.1, 31-46.

  65. Jackson, Hollie J., Rafiq, Sarwish, Brentjens, Renier J.. Driving CAR T-cells forward. Nature reviews. Clinical oncology, vol.13, no.6, 370-383.

  66. Wang, Y., Zhang, W.y., Han, Q.w., Liu, Y., Dai, H.r., Guo, Y.l., Bo, J., Fan, H., Zhang, Y., Zhang, Y.j., Chen, M.x., Feng, K.c., Wang, Q.s., Fu, X.b., Han, W.d.. Effective response and delayed toxicities of refractory advanced diffuse large B-cell lymphoma treated by CD20-directed chimeric antigen receptor-modified T cells. Clinical immunology : the official journal of the Clinical Immunology Society, vol.155, no.2, 160-175.

  67. Zah, Eugenia, Lin, Meng-Yin, Silva-Benedict, Anne, Jensen, Michael C., Chen, Yvonne Y.. T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells. Cancer immunology research, vol.4, no.6, 498-508.

  68. Haso, Waleed, Lee, Daniel W., Shah, Nirali N., Stetler-Stevenson, Maryalice, Yuan, Constance M., Pastan, Ira H., Dimitrov, Dimiter S., Morgan, Richard A., FitzGerald, David J., Barrett, David M., Wayne, Alan S., Mackall, Crystal L., Orentas, Rimas J.. Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia. Blood, vol.121, no.7, 1165-1174.

  69. Kenderian, S S, Ruella, M, Shestova, O, Klichinsky, M, Aikawa, V, Morrissette, J J D, Scholler, J, Song, D, Porter, D L, Carroll, M, June, C H, Gill, S. CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, vol.29, no.8, 1637-1647.

  70. Wang, Quan-shun, Wang, Yao, Lv, Hai-yan, Han, Qing-wang, Fan, Hui, Guo, Bo, Wang, Li-li, Han, Wei-dong. Treatment of CD33-directed Chimeric Antigen Receptor-modified T Cells in One Patient With Relapsed and Refractory Acute Myeloid Leukemia. Molecular therapy : the journal of the American Society of Gene Therapy, vol.23, no.1, 184-191.

  71. Gill, Saar, Tasian, Sarah K., Ruella, Marco, Shestova, Olga, Li, Yong, Porter, David L., Carroll, Martin, Danet-Desnoyers, Gwenn, Scholler, John, Grupp, Stephan A., June, Carl H., Kalos, Michael. Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor–modified T cells. Blood, vol.123, no.15, 2343-2354.

  72. Heczey, Andras, Louis, Chrystal U., Savoldo, Barbara, Dakhova, Olga, Durett, April, Grilley, Bambi, Liu, Hao, Wu, Mengfeng F., Mei, Zhuyong, Gee, Adrian, Mehta, Birju, Zhang, Huimin, Mahmood, Nadia, Tashiro, Haruko, Heslop, Helen E., Dotti, Gianpietro, Rooney, Cliona M., Brenner, Malcolm K.. CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma. Molecular therapy : the journal of the American Society of Gene Therapy, vol.25, no.9, 2214-2224.

  73. Hassan, Raffit, Thomas, Anish, Alewine, Christine, Le, Dung T., Jaffee, Elizabeth M., Pastan, Ira. Mesothelin Immunotherapy for Cancer: Ready for Prime Time?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.34, no.34, 4171-4179.

  74. Lanitis, Evripidis, Poussin, Mathilde, Hagemann, Ian S, Coukos, George, Sandaltzopoulos, Raphael, Scholler, Nathalie, Powell Jr, Daniel J. Redirected Antitumor Activity of Primary Human Lymphocytes Transduced With a Fully Human Anti-mesothelin Chimeric Receptor. Molecular therapy : the journal of the American Society of Gene Therapy, vol.20, no.3, 633-643.

  75. Beatty, Gregory L., Haas, Andrew R., Maus, Marcela V., Torigian, Drew A., Soulen, Michael C., Plesa, Gabriela, Chew, Anne, Zhao, Yangbing, Levine, Bruce L., Albelda, Steven M., Kalos, Michael, June, Carl H.. Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies. Cancer immunology research, vol.2, no.2, 112-120.

  76. O’Rourke, Donald M., Nasrallah, MacLean P., Desai, Arati, Melenhorst, Jan J., Mansfield, Keith, Morrissette, Jennifer J. D., Martinez-Lage, Maria, Brem, Steven, Maloney, Eileen, Shen, Angela, Isaacs, Randi, Mohan, Suyash, Plesa, Gabriela, Lacey, Simon F., Navenot, Jean-Marc, Zheng, Zhaohui, Levine, Bruce L., Okada, Hideho, June, Carl H., Brogdon, Jennifer L., Maus, Marcela V.. A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma. Science translational medicine, vol.9, no.399, eaaa0984-eaaa0984.

  77. Debinski, Waldemar, Gibo, Denise M., Obiri, Nicholas I., Kealiher, Aynsley, Puri, Raj K.. Novel anti-brain tumor cytotoxins specific for cancer cells. Nature biotechnology, vol.16, no.5, 449-453.

  78. Brown, Christine E., Badie, Behnam, Barish, Michael E., Weng, Lihong, Ostberg, Julie R., Chang, Wen-Chung, Naranjo, Araceli, Starr, Renate, Wagner, Jamie, Wright, Christine, Zhai, Yubo, Bading, James R., Ressler, Julie A., Portnow, Jana, D'Apuzzo, Massimo, Forman, Stephen J., Jensen, Michael C.. Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma. Clinical Cancer research : an official journal of the American Association for Cancer Research, vol.21, no.18, 4062-4072.

  79. Brown, Christine E., Alizadeh, Darya, Starr, Renate, Weng, Lihong, Wagner, Jamie R., Naranjo, Araceli, Ostberg, Julie R., Blanchard, M. Suzette, Kilpatrick, Julie, Simpson, Jennifer, Kurien, Anita, Priceman, Saul J., Wang, Xiuli, Harshbarger, Todd L., D’Apuzzo, Massimo, Ressler, Julie A., Jensen, Michael C., Barish, Michael E., Chen, Mike, Portnow, Jana, Forman, Stephen J., Badie, Behnam. Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy. The New England journal of medicine, vol.375, no.26, 2561-2569.

  80. Mamonkin, Maksim, Rouce, Rayne H., Tashiro, Haruko, Brenner, Malcolm K.. A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies. Blood, vol.126, no.8, 983-992.

  81. Caruso, Hillary G., Hurton, Lenka V., Najjar, Amer, Rushworth, David, Ang, Sonny, Olivares, Simon, Mi, Tiejuan, Switzer, Kirsten, Singh, Harjeet, Huls, Helen, Lee, Dean A., Heimberger, Amy B., Champlin, Richard E., Cooper, Laurence J.N.. Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity. Cancer research : the official organ of the American Association for Cancer Research, Inc, vol.75, no.17, 3505-3518.

  82. Liu, Xiaojun, Jiang, Shuguang, Fang, Chongyun, Yang, Shiyu, Olalere, Devvora, Pequignot, Edward C., Cogdill, Alexandria P., Li, Na, Ramones, Melissa, Granda, Brian, Zhou, Li, Loew, Andreas, Young, Regina M., June, Carl H., Zhao, Yangbing. Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice. Cancer research : the official organ of the American Association for Cancer Research, Inc, vol.75, no.17, 3596-3607.

  83. Posey, Avery D., Schwab, Robert D., Boesteanu, Alina C., Steentoft, C., Mandel, U., Engels, B., Stone, Jennifer D., Madsen, Thomas D., Schreiber, K., Haines, Kathleen M., Cogdill, Alexandria P., Chen, Taylor J., Song, D., Scholler, J., Kranz, David M., Feldman, Michael D., Young, R., Keith, B., Schreiber, H., Clausen, H., Johnson, Laura A., June, Carl H.. Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma. Immunity, vol.44, no.6, 1444-1454.

  84. Graef, P., Buchholz, Veit R., Stemberger, C., Flossdorf, M., Henkel, L., Schiemann, M., Drexler, I., Hofer, T., Riddell, Stanley R., Busch, Dirk H.. Serial Transfer of Single-Cell-Derived Immunocompetence Reveals Stemness of CD8+ Central Memory T Cells. Immunity, vol.41, no.1, 116-126.

  85. Klebanoff, Christopher A., Scott, Christopher D., Leonardi, Anthony J., Yamamoto, Tori N., Cruz, Anthony C., Ouyang, Claudia, Ramaswamy, Madhu, Roychoudhuri, Rahul, Ji, Yun, Eil, Robert L., Sukumar, Madhusudhanan, Crompton, Joseph G., Palmer, Douglas C., Borman, Zachary A., Clever, David, Thomas, Stacy K., Patel, Shashankkumar, Yu, Zhiya, Muranski, Pawel, Liu, Hui, Wang, Ena, Marincola, Francesco M., Gros, Alena, Gattinoni, Luca, Rosenberg, Steven A., Siegel, Richard M., Restifo, Nicholas P.. Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy. The Journal of clinical investigation, vol.126, no.1, 318-334.

  86. Busch, D.H., Fraszle, S.P., Sommermeyer, D., Buchholz, V.R., Riddell, S.R.. Role of memory T cell subsets for adoptive immunotherapy. Seminars in immunology, vol.28, no.1, 28-34.

  87. Gattinoni, Luca, Speiser, Daniel E, Lichterfeld, Mathias, Bonini, Chiara. T memory stem cells in health and disease. Nature medicine, vol.23, no.1, 18-27.

  88. Klebanoff, Christopher A., Gattinoni, Luca, Torabi-Parizi, Parizad, Kerstann, Keith, Cardones, Adela R., Finkelstein, Steven E., Palmer, Douglas C., Antony, Paul A., Hwang, Sam T., Rosenberg, Steven A., Waldmann, Thomas A., Restifo, Nicholas P.. Central memory self/tumor-reactive CD8 + T cells confer superior antitumor immunity compared with effector memory T cells. Proceedings of the National Academy of Sciences of the United States of America, vol.102, no.27, 9571-9576.

  89. Berger, Carolina, Jensen, Michael C., Lansdorp, Peter M., Gough, Mike, Elliott, Carole, Riddell, Stanley R.. Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. The Journal of clinical investigation, vol.118, no.1, 294-305.

  90. Thomas, Anna K., Maus, Marcela V., Shalaby, Waleed S., June, Carl H., Riley, James L.. A Cell-Based Artificial Antigen-Presenting Cell Coated with Anti-CD3 and CD28 Antibodies Enables Rapid Expansion and Long-Term Growth of CD4 T Lymphocytes. Clinical immunology : the official journal of the Clinical Immunology Society, vol.105, no.3, 259-272.

  91. Maus, Marcela V., Thomas, Anna K., Leonard, Debra G.B., Allman, David, Addya, Kathakali, Schlienger, Katia, Riley, James L., June, Carl H.. Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB. Nature biotechnology, vol.20, no.2, 143-148.

  92. Xu, Yang, Zhang, Ming, Ramos, Carlos A., Durett, April, Liu, Enli, Dakhova, Olga, Liu, Hao, Creighton, Chad J., Gee, Adrian P., Heslop, Helen E., Rooney, Cliona M., Savoldo, Barbara, Dotti, Gianpietro. Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15. Blood, vol.123, no.24, 3750-3759.

  93. Gattinoni, Luca, Zhong, Xiao-Song, Palmer, Douglas C, Ji, Yun, Hinrichs, Christian S, Yu, Zhiya, Wrzesinski, Claudia, Boni, Andrea, Cassard, Lydie, Church, Lindsay, Paulos, Chrystal M, Muranski, Pawel, Restifo, Nicholas P. Wnt signaling arrests effector T cell differentiation and generates CD8 + memory stem cells. Nature medicine, vol.15, no.7, 808-813.

  94. Cieri, Nicoletta, Camisa, Barbara, Cocchiarella, Fabienne, Forcato, Mattia, Oliveira, Giacomo, Provasi, Elena, Bondanza, Attilio, Bordignon, Claudio, Peccatori, Jacopo, Ciceri, Fabio, Lupo-Stanghellini, Maria Teresa, Mavilio, Fulvio, Mondino, Anna, Bicciato, Silvio, Recchia, Alessandra, Bonini, Chiara. IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors. Blood, vol.121, no.4, 573-584.

  95. Crompton, Joseph G., Sukumar, Madhusudhanan, Roychoudhuri, Rahul, Clever, David, Gros, Alena, Eil, Robert L., Tran, Eric, Hanada, Ken-ichi, Yu, Zhiya, Palmer, Douglas C., Kerkar, Sid P., Michalek, Ryan D., Upham, Trevor, Leonardi, Anthony, Acquavella, Nicolas, Wang, Ena, Marincola, Francesco M., Gattinoni, Luca, Muranski, Pawel, Sundrud, Mark S., Klebanoff, Christopher A., Rosenberg, Steven A., Fearon, Douglas T., Restifo, Nicholas P.. Akt Inhibition Enhances Expansion of Potent Tumor-Specific Lymphocytes with Memory Cell Characteristics. Cancer research : the official organ of the American Association for Cancer Research, Inc, vol.75, no.2, 296-305.

  96. Geiger, Roger, Rieckmann, Jan C., Wolf, Tobias, Basso, Camilla, Feng, Yuehan, Fuhrer, Tobias, Kogadeeva, Maria, Picotti, Paola, Meissner, Felix, Mann, Matthias, Zamboni, Nicola, Sallusto, Federica, Lanzavecchia, Antonio. L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity. Cell, vol.167, no.3, 829-842.e13.

  97. Wang, Xiuli, Naranjo, Araceli, Brown, Christine E., Bautista, Cherrilyn, Wong, ChingLam W., Chang, Wen-Chung, Aguilar, Brenda, Ostberg, Julie R., Riddell, Stanley R., Forman, Stephen J., Jensen, Michael C.. Phenotypic and Functional Attributes of Lentivirus-modified CD19-specific Human CD8+ Central Memory T Cells Manufactured at Clinical Scale. Journal of immunotherapy, vol.35, no.9, 689-701.

  98. Wang, Xiuli, Popplewell, Leslie L., Wagner, Jamie R., Naranjo, Araceli, Blanchard, M. Suzette, Mott, Michelle R., Norris, Adam P., Wong, ChingLam W., Urak, Ryan Z., Chang, Wen-Chung, Khaled, Samer K., Siddiqi, Tanya, Budde, Lihua E., Xu, Jingying, Chang, Brenda, Gidwaney, Nikita, Thomas, Sandra H., Cooper, Laurence J. N., Riddell, Stanley R., Brown, Christine E., Jensen, Michael C., Forman, Stephen J.. Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL. Blood, vol.127, no.24, 2980-2990.

  99. Wherry, E John. T cell exhaustion. Nature immunology, vol.12, no.6, 492-499.

  100. Wherry, E. John, Kurachi, Makoto. Molecular and cellular insights into T cell exhaustion. Nature reviews. Immunology, vol.15, no.8, 486-499.

  101. Ren, Jiangtao, Liu, Xiaojun, Fang, Chongyun, Jiang, Shuguang, June, Carl H., Zhao, Yangbing. Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition. Clinical Cancer research : an official journal of the American Association for Cancer Research, vol.23, no.9, 2255-2266.

  102. Moeller, Maria, Haynes, Nicole M., Kershaw, Michael H., Jackson, Jacob T., Teng, Michele W. L., Street, Shayna E., Cerutti, Loretta, Jane, Stephen M., Trapani, Joseph A., Smyth, Mark J., Darcy, Phillip K.. Adoptive transfer of gene-engineered CD4+ helper T cells induces potent primary and secondary tumor rejection. Blood, vol.106, no.9, 2995-3003.

  103. Moeller, Maria, Kershaw, Michael H., Cameron, Rachel, Westwood, Jennifer A., Trapani, Joseph A., Smyth, Mark J., Darcy, Phillip K.. Sustained Antigen-Specific Antitumor Recall Response Mediated by Gene-Modified CD4+ T Helper-1 and CD8+ T Cells. Cancer research : the official organ of the American Association for Cancer Research, Inc, vol.67, no.23, 11428-11437.

  104. Sommermeyer, Daniel, Hudecek, Michael, Kosasih, Paula L., Gogishvili, Tea, Maloney, David G., Turtle, Cameron J., Riddell, Stanley R.. Chimeric antigen receptor-modified T cells derived from defined CD8 + and CD4 + subsets confer superior antitumor reactivity in vivo. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, vol.30, no.2, 492-500.

  105. Tran, Eric, Turcotte, Simon, Gros, Alena, Robbins, Paul F., Lu, Yong-Chen, Dudley, Mark E., Wunderlich, John R., Somerville, Robert P., Hogan, Katherine, Hinrichs, Christian S., Parkhurst, Maria R., Yang, James C., Rosenberg, Steven A.. Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer. Science, vol.344, no.6184, 641-645.

  106. Liadi, Ivan, Singh, Harjeet, Romain, Gabrielle, Rey-Villamizar, Nicolas, Merouane, Amine, Adolacion, Jay R T., Kebriaei, Partow, Huls, Helen, Qiu, Peng, Roysam, Badrinath, Cooper, Laurence J.N., Varadarajan, Navin. Individual Motile CD4+ T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells. Cancer immunology research, vol.3, no.5, 473-482.

  107. Neelapu, Sattva S., Tummala, Sudhakar, Kebriaei, Partow, Wierda, William, Gutierrez, Cristina, Locke, Frederick L., Komanduri, Krishna V., Lin, Yi, Jain, Nitin, Daver, Naval, Westin, Jason, Gulbis, Alison M., Loghin, Monica E., de Groot, John F., Adkins, Sherry, Davis, Suzanne E., Rezvani, Katayoun, Hwu, Patrick, Shpall, Elizabeth J.. Chimeric antigen receptor T-cell therapy — assessment and management of toxicities. Nature reviews. Clinical oncology, vol.15, no.1, 47-62.

  108. Speiser, Daniel E., Ho, Ping-Chih, Verdeil, Grégory. Regulatory circuits of T cell function in cancer. Nature reviews. Immunology, vol.16, no.10, 599-611.

  109. Harlin, Helena, Meng, Yuru, Peterson, Amy C., Zha, Yuanyuan, Tretiakova, Maria, Slingluff, Craig, McKee, Mark, Gajewski, Thomas F.. Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment. Cancer research : the official organ of the American Association for Cancer Research, Inc, vol.69, no.7, 3077-3085.

  110. Gajewski, Thomas F, Schreiber, Hans, Fu, Yang-Xin. Innate and adaptive immune cells in the tumor microenvironment. Nature immunology, vol.14, no.10, 1014-1022.

  111. Di Stasi, Antonio, De Angelis, Biagio, Rooney, Cliona M., Zhang, Lan, Mahendravada, Aruna, Foster, Aaron E., Heslop, Helen E., Brenner, Malcolm K., Dotti, Gianpietro, Savoldo, Barbara. T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model. Blood, vol.113, no.25, 6392-6402.

  112. Moon, Edmund K., Carpenito, Carmine, Sun, Jing, Wang, Liang-Chuan S., Kapoor, Veena, Predina, Jarrod, Powell Jr., Daniel J., Riley, James L., June, Carl H., Albelda, Steven M.. Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor. Clinical Cancer research : an official journal of the American Association for Cancer Research, vol.17, no.14, 4719-4730.

  113. Newick, Kheng, O'Brien, Shaun, Sun, Jing, Kapoor, Veena, Maceyko, Steven, Lo, Albert, Puré, Ellen, Moon, Edmund, Albelda, Steven M.. Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization. Cancer immunology research, vol.4, no.6, 541-551.

  114. Li, Si, Siriwon, Natnaree, Zhang, Xiaoyang, Yang, Shuai, Jin, Tao, He, Feng, Kim, Yu Jeong, Mac, John, Lu, Zhengfei, Wang, Sijie, Han, Xiaolu, Wang, Pin. Enhanced Cancer Immunotherapy by Chimeric Antigen Receptor–Modified T Cells Engineered to Secrete Checkpoint Inhibitors. Clinical Cancer research : an official journal of the American Association for Cancer Research, vol.23, no.22, 6982-6992.

  115. Kloss, Christopher C, Condomines, Maud, Cartellieri, Marc, Bachmann, Michael, Sadelain, Michel. Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells. Nature biotechnology, vol.31, no.1, 71-75.

  116. Wang, Xiuli, Chang, Wen-Chung, Wong, ChingLam W., Colcher, David, Sherman, Mark, Ostberg, Julie R., Forman, Stephen J., Riddell, Stanley R., Jensen, Michael C.. A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells. Blood, vol.118, no.5, 1255-1263.

  117. Gardner, Rebecca A., Finney, Olivia, Annesley, Colleen, Brakke, Hannah, Summers, Corinne, Leger, Kasey, Bleakley, Marie, Brown, Christopher, Mgebroff, Stephanie, Kelly-Spratt, Karen S., Hoglund, Virginia, Lindgren, Catherine, Oron, Assaf P., Li, Daniel, Riddell, Stanley R., Park, Julie R., Jensen, Michael C.. Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults. Blood, vol.129, no.25, 3322-3331.

  118. Cartellieri, Marc, Koristka, Stefanie, Arndt, Claudia, Feldmann, Anja, Stamova, Slava, von Bonin, Malte, Töpfer, Katrin, Krüger, Thomas, Geib, Mathias, Michalk, Irene, Temme, Achim, Bornhäuser, Martin, Lindemann, Dirk, Ehninger, Gerhard, Bachmann, Michael P.. A Novel Ex Vivo Isolation and Expansion Procedure for Chimeric Antigen Receptor Engrafted Human T Cells. PloS one, vol.9, no.4, e93745-.

  119. Ma, Jennifer S. Y., Kim, Ji Young, Kazane, Stephanie A., Choi, Sei-hyun, Yun, Hwa Young, Kim, Min Soo, Rodgers, David T., Pugh, Holly M., Singer, Oded, Sun, Sophie B., Fonslow, Bryan R., Kochenderfer, James N., Wright, Timothy M., Schultz, Peter G., Young, Travis S., Kim, Chan Hyuk, Cao, Yu. Versatile strategy for controlling the specificity and activity of engineered T cells. Proceedings of the National Academy of Sciences of the United States of America, vol.113, no.4, E450-E458.

  120. Rodgers, David T., Mazagova, Magdalena, Hampton, Eric N., Cao, Yu, Ramadoss, Nitya S., Hardy, Ian R., Schulman, Andrew, Du, Juanjuan, Wang, Feng, Singer, Oded, Ma, Jennifer, Nunez, Vanessa, Shen, Jiayin, Woods, Ashley K., Wright, Timothy M., Schultz, Peter G., Kim, Chan Hyuk, Young, Travis S.. Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies. Proceedings of the National Academy of Sciences of the United States of America, vol.113, no.4, E459-E468.

  121. Albert, Susann, Arndt, Claudia, Feldmann, Anja, Bergmann, Ralf, Bachmann, Dominik, Koristka, Stefanie, Ludwig, Florian, Ziller-Walter, Pauline, Kegler, Alexandra, Gärtner, Sebastian, Schmitz, Marc, Ehninger, Armin, Cartellieri, Marc, Ehninger, Gerhard, Pietzsch, Hans-Jürgen, Pietzsch, Jens, Steinbach, Jörg, Bachmann, Michael. A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform. Oncoimmunology, vol.6, no.4, e1287246-.

  122. Aldoss, I, Bargou, R C, Nagorsen, D, Friberg, G R, Baeuerle, P A, Forman, S J. Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, vol.31, no.4, 777-787.

  123. Jones, Benjamin S., Lamb, Lawrence S., Goldman, Frederick, Di Stasi, Antonio. Improving the safety of cell therapy products by suicide gene transfer. Frontiers in pharmacology, vol.5, 254-.

  124. Diaconu, Iulia, Ballard, Brandon, Zhang, Ming, Chen, Yuhui, West, John, Dotti, Gianpietro, Savoldo, Barbara. Inducible Caspase-9 Selectively Modulates the Toxicities of CD19-Specific Chimeric Antigen Receptor-Modified T Cells. Molecular therapy : the journal of the American Society of Gene Therapy, vol.25, no.3, 580-592.

  125. Keu, Khun Visith, Witney, Timothy H., Yaghoubi, Shahriar, Rosenberg, Jarrett, Kurien, Anita, Magnusson, Rachel, Williams, John, Habte, Frezghi, Wagner, Jamie R., Forman, Stephen, Brown, Christine, Allen-Auerbach, Martin, Czernin, Johannes, Tang, Winson, Jensen, Michael C., Badie, Behnam, Gambhir, Sanjiv S.. Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma. Science translational medicine, vol.9, no.373, eaag2196-eaag2196.

  126. Wu, Chia-Yung, Roybal, Kole T., Puchner, Elias M., Onuffer, James, Lim, Wendell A.. Remote control of therapeutic T cells through a small molecule–gated chimeric receptor. Science, vol.350, no.6258, aab4077-aab4077.

  127. Sheridan, Cormac. First approval in sight for Novartis' CAR-T therapy after panel vote. Nature biotechnology, vol.35, no.8, 691-693.

  128. Kebriaei, Partow, Singh, Harjeet, Huls, M. Helen, Figliola, Matthew J., Bassett, Roland, Olivares, Simon, Jena, Bipulendu, Dawson, Margaret J., Kumaresan, Pappanaicken R., Su, Shihuang, Maiti, Sourindra, Dai, Jianliang, Moriarity, Branden, Forget, Marie-Andrée, Senyukov, Vladimir, Orozco, Aaron, Liu, Tingting, McCarty, Jessica, Jackson, Rineka N., Moyes, Judy S., Rondon, Gabriela, Qazilbash, Muzaffar, Ciurea, Stefan, Alousi, Amin, Nieto, Yago, Rezvani, Katy, Marin, David, Popat, Uday, Hosing, Chitra, Shpall, Elizabeth J., Kantarjian, Hagop, Keating, Michael, Wierda, William, Do, Kim Anh, Largaespada, David A., Lee, Dean A., Hackett, Perry B., Champlin, Richard E., Cooper, Laurence J.N.. Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells. The Journal of clinical investigation, vol.126, no.9, 3363-3376.

  129. Caruso, Hillary G., Torikai, Hiroki, Zhang, Ling, Maiti, Sourindra, Dai, Jianliang, Do, Kim-Anh, Singh, Harjeet, Huls, Helen, Lee, Dean A., Champlin, Richard E., Heimberger, Amy B., Cooper, Laurence J.N.. Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen Receptor. Journal of immunotherapy, vol.39, no.5, 205-217.

  130. Tasian, Sarah K., Kenderian, Saad S., Shen, Feng, Ruella, Marco, Shestova, Olga, Kozlowski, Miroslaw, Li, Yong, Schrank-Hacker, April, Morrissette, Jennifer J. D., Carroll, Martin, June, Carl H., Grupp, Stephan A., Gill, Saar. Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemia. Blood, vol.129, no.17, 2395-2407.

  131. Smith, Tyrel T., Stephan, Sirkka B., Moffett, Howell F., McKnight, Laura E., Ji, Weihang, Reiman, Diana, Bonagofski, Emmy, Wohlfahrt, Martin E., Pillai, Smitha P. S., Stephan, Matthias T.. In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers. Nature nanotechnology, vol.12, no.8, 813-820.

  132. Olweus, Johanna. Manufacture of CAR-T cells in the body. Nature biotechnology, vol.35, no.6, 520-521.

  133. Gattinoni, Luca, Finkelstein, Steven E., Klebanoff, Christopher A., Antony, Paul A., Palmer, Douglas C., Spiess, Paul J., Hwang, Leroy N., Yu, Zhiya, Wrzesinski, Claudia, Heimann, David M., Surh, Charles D., Rosenberg, Steven A., Restifo, Nicholas P.. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8 + T cells. The Journal of experimental medicine, vol.202, no.7, 907-912.

  134. Dudley, Mark E., Yang, James C., Sherry, Richard, Hughes, Marybeth S., Royal, Richard, Kammula, Udai, Robbins, Paul F., Huang, JianPing, Citrin, Deborah E., Leitman, Susan F., Wunderlich, John, Restifo, Nicholas P., Thomasian, Armen, Downey, Stephanie G., Smith, Franz O., Klapper, Jacob, Morton, Kathleen, Laurencot, Carolyn, White, Donald E., Rosenberg, Steven A.. Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.26, no.32, 5233-5239.

  135. Wolchok, Jedd D., Chiarion-Sileni, Vanna, Gonzalez, Rene, Rutkowski, Piotr, Grob, Jean-Jacques, Cowey, C. Lance, Lao, Christopher D., Wagstaff, John, Schadendorf, Dirk, Ferrucci, Pier F., Smylie, Michael, Dummer, Reinhard, Hill, Andrew, Hogg, David, Haanen, John, Carlino, Matteo S., Bechter, Oliver, Maio, Michele, Marquez-Rodas, Ivan, Guidoboni, Massimo, McArthur, Grant, Lebbé, Celeste, Ascierto, Paolo A., Long, Georgina V., Cebon, Jonathan, Sosman, Jeffrey, Postow, Michael A., Callahan, Margaret K., Walker, Dana, Rollin, Linda, Bhore, Rafia, Hodi, F. Stephen, Larkin, James. Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. The New England journal of medicine, vol.377, no.14, 1345-1356.

  136. Hellmann, Matthew D, Rizvi, Naiyer A, Goldman, Jonathan W, Gettinger, Scott N, Borghaei, Hossein, Brahmer, Julie R, Ready, Neal E, Gerber, David E, Chow, Laura Q, Juergens, Rosalyn A, Shepherd, Frances A, Laurie, Scott A, Geese, William J, Agrawal, Shruti, Young, Tina C, Li, Xuemei, Antonia, Scott J. Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study. The Lancet. Oncology, vol.18, no.1, 31-41.

  137. Ferris, Robert L., Blumenschein Jr., George, Fayette, Jerome, Guigay, Joel, Colevas, A. Dimitrios, Licitra, Lisa, Harrington, Kevin, Kasper, Stefan, Vokes, Everett E., Even, Caroline, Worden, Francis, Saba, Nabil F., Iglesias Docampo, Lara C., Haddad, Robert, Rordorf, Tamara, Kiyota, Naomi, Tahara, Makoto, Monga, Manish, Lynch, Mark, Geese, William J., Kopit, Justin, Shaw, James W., Gillison, Maura L.. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. The New England journal of medicine, vol.375, no.19, 1856-1867.

  138. 10.1200/JCO.2016.72.1985JCO2016721985 

  139. Huang, Alexander C., Postow, Michael A., Orlowski, Robert J., Mick, Rosemarie, Bengsch, Bertram, Manne, Sasikanth, Xu, Wei, Harmon, Shannon, Giles, Josephine R., Wenz, Brandon, Adamow, Matthew, Kuk, Deborah, Panageas, Katherine S., Carrera, Cristina, Wong, Phillip, Quagliarello, Felix, Wubbenhorst, Bradley, D’Andrea, Kurt, Pauken, Kristen E., Herati, Ramin S., Staupe, Ryan P., Schenkel, Jason M., McGettigan, Suzanne, Kothari, Shawn, George, Sangeeth M., Vonderheide, Robert H., Amaravadi, Ravi K., Karakousis, Giorgos C., Schuchter, Lynn M., Xu, Xiaowei, Nathanson, Katherine L., Wolchok, Jedd D., Gangadhar, Tara C., Wherry, E. John. T-cell invigoration to tumour burden ratio associated with anti-PD-1 response. Nature, vol.545, no.7652, 60-65.

  140. John, Liza B., Devaud, Christel, Duong, Connie P.M., Yong, Carmen S., Beavis, Paul A., Haynes, Nicole M., Chow, Melvyn T., Smyth, Mark J., Kershaw, Michael H., Darcy, Phillip K.. Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells. Clinical Cancer research : an official journal of the American Association for Cancer Research, vol.19, no.20, 5636-5646.

  141. Gargett, Tessa, Yu, Wenbo, Dotti, Gianpietro, Yvon, Eric S, Christo, Susan N, Hayball, John D, Lewis, Ian D, Brenner, Malcolm K, Brown, Michael P. GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade. Molecular therapy : the journal of the American Society of Gene Therapy, vol.24, no.6, 1135-1149.

  142. Serganova, Inna, Moroz, Ekaterina, Cohen, Ivan, Moroz, Maxim, Mane, Mayuresh, Zurita, Juan, Shenker, Larissa, Ponomarev, Vladimir, Blasberg, Ronald. Enhancement of PSMA-Directed CAR Adoptive Immunotherapy by PD-1/PD-L1 Blockade. Molecular therapy oncolytics, vol.4, 41-54.

  143. Poirot, Laurent, Philip, Brian, Schiffer-Mannioui, Cécile, Le Clerre, Diane, Chion-Sotinel, Isabelle, Derniame, Sophie, Potrel, Pierrick, Bas, Cécile, Lemaire, Laetitia, Galetto, Roman, Lebuhotel, Céline, Eyquem, Justin, Cheung, Gordon Weng-Kit, Duclert, Aymeric, Gouble, Agnès, Arnould, Sylvain, Peggs, Karl, Pule, Martin, Scharenberg, Andrew M., Smith, Julianne. Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell Immunotherapies. Cancer research : the official organ of the American Association for Cancer Research, Inc, vol.75, no.18, 3853-3864.

  144. Reardon, Sara. Leukaemia success heralds wave of gene-editing therapies. Nature, vol.527, no.7577, 146-147.

  145. Couzin-Frankel, Jennifer. Baby's leukemia recedes after novel cell therapy. Science, vol.350, no.6262, 731-731.

  146. Eyquem, Justin, Mansilla-Soto, Jorge, Giavridis, Theodoros, van der Stegen, Sjoukje J. C., Hamieh, Mohamad, Cunanan, Kristen M., Odak, Ashlesha, Gönen, Mithat, Sadelain, Michel. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection. Nature, vol.543, no.7643, 113-117.

LOADING...
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로